GLP-1 promoter mediated insulin expression for the treatment of diabetes.
Insulin gene therapy is one of many envisioned alternative treatments of diabetes. Diabetes gene therapy would be possible if insulin could be produced in a regulated and specifically in a sensitive manner dependent on the blood glucose level.Therefore, the present invention relates to a method for...
| Main Authors: | , , |
|---|---|
| Format: | Patent |
| Language: | English |
| Published: |
2010
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/32198/1/US20140112895A1.pdf |